Humoral response profiling reveals pathways to prostate cancer progression (Q46852385)

25 December 2017

title

Humoral response profiling reveals pathways to prostate cancer progression (English)

1 reference

25 December 2017

1 reference

Alexey I. Nesvizhskii

9

1 reference

25 December 2017

Gil Omenn

11

1 reference

25 December 2017

Shanker Kalyana-Sundaram

object named as

Shanker Kalyana-Sundaram

5

0 references

author name string

Barry S Taylor

1

1 reference

25 December 2017

Manoj Pal

2

1 reference

25 December 2017

Jianjun Yu

3

1 reference

25 December 2017

Bharathi Laxman

4

1 reference

25 December 2017

Rong Zhao

6

1 reference

25 December 2017

Anjana Menon

7

1 reference

25 December 2017

John T Wei

8

1 reference

25 December 2017

Debashis Ghosh

10

1 reference

25 December 2017

David M Lubman

12

1 reference

25 December 2017

Arul M Chinnaiyan

13

1 reference

25 December 2017

Arun Sreekumar

14

1 reference

25 December 2017

publication date

11 December 2007

1 reference

25 December 2017

Molecular & Cellular Proteomics

published in

1 reference

25 December 2017

volume

7

1 reference

25 December 2017

page(s)

600-611

1 reference

25 December 2017

issue

3

1 reference

25 December 2017

cites work

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700263-MCP200

Management of cancer of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700263-MCP200

Proteomic applications for the early detection of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700263-MCP200

The human plasma proteome: a nonredundant list developed by combination of four separate sources

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700263-MCP200

An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700263-MCP200

Fingerprinting the circulating repertoire of antibodies from cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700263-MCP200

Autoantibodies to prostasomes as new markers for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700263-MCP200

Humoral immune response to alpha-methylacyl-CoA racemase and prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700263-MCP200

Autoantibody signatures in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700263-MCP200

Cluster analysis and display of genome-wide expression patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700263-MCP200

Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700263-MCP200

Phosphotyrosine interactome of the ErbB-receptor kinase family

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700263-MCP200

A statistical model for identifying proteins by tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700263-MCP200

Integrative molecular concept modeling of prostate cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700263-MCP200

Immune response in silico (IRIS): immune-specific genes identified from a compendium of microarray expression data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700263-MCP200

Survival in early breast cancer patients is favorably influenced by a natural humoral immune response to polymorphic epithelial mucin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700263-MCP200

TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700263-MCP200

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700263-MCP200

RNA interference targeting Stat3 inhibits growth and induces apoptosis of human prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700263-MCP200

Delineation of prognostic biomarkers in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700263-MCP200

Gene expression analysis of prostate cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700263-MCP200

Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700263-MCP200

Characterization of prostate cancer missed by sextant biopsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700263-MCP200

Restoration of fibroblast growth factor receptor2 suppresses growth and tumorigenicity of malignant human prostate carcinoma PC-3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700263-MCP200

Signaling initiated by overexpression of the fibroblast growth factor receptor-1 investigated by mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700263-MCP200

The role of fibroblast growth factors and their receptors in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700263-MCP200

Protein microarrays using liquid phase fractionation of cell lysates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700263-MCP200

Microarrays of tumor cell derived proteins uncover a distinct pattern of prostate cancer serum immunoreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700263-MCP200

Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700263-MCP200

Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700263-MCP200

Proteomic analysis of autoantibodies in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700263-MCP200

Constitutive activation of JAK-STAT3 signaling by BRCA1 in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700263-MCP200

Studies on the chemical basis of the antigenicity of proteins. 5. Synthesis, characterization and immunogenicity of some multichain and linear polypeptides containing tyrosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700263-MCP200

10.1074/MCP.M700263-MCP200

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

PubMed ID

18077443

1 reference

25 December 2017